European Patent Office publication EP4543425A1 details a patent application for a Plectranthus Amboinicus extract intended for the treatment of radiation-induced skin disorders. The application, filed by Oneness Biotech Co., Ltd., was published on March 18, 2026, and includes various IPC classifications related to medicinal preparations and skin treatments.

This publication represents a new patent filing and does not impose immediate compliance obligations on regulated entities. However, it signifies potential future developments in pharmaceutical treatments for radiation side effects. Companies involved in dermatology, oncology supportive care, or botanical drug development should note this filing as it pertains to novel therapeutic applications.